Ukraine's regulatory trajectory aligns with the EU Medical Device Regulation (MDR) through ongoing European integration reforms. Understanding the European CE marking process—with its emphasis on clinical evidence and post-market surveillance—directly informs how Ukrainian hospitals should evaluate AI diagnostic tools.
Author: Yoman
[Medical ML] US Experience: FDA-Approved AI Devices
As Ukraine develops its regulatory framework for medical AI (aligned with EU MDR through recent reforms), understanding the world's largest medical AI market provides invaluable lessons. The US FDA has authorized over 1,200 AI/ML-enabled medical devices—more than any other regulatory body—making it the de facto testing ground for medical AI deployment.
[Medical ML] Regulatory Landscape for Medical AI: FDA, CE Marking, and Ukrainian MHSU
For ScanLab and any medical AI initiative targeting Ukrainian healthcare, regulatory compliance isn't optional—it's existential. Understanding the regulatory landscape determines:


